中文名称 | 英文名称 | CAS号 | 化学式 | 分子量 |
---|---|---|---|---|
非布索坦 | febuxostat | 144060-53-7 | C16H16N2O3S | 316.381 |
2-(3-醛基-4-异丁氧基苯基)-4-甲基噻唑-5-甲酸乙酯 | ethyl 2-(3-formyl-4-isobutoxyphenyl)-4-methylthiazole-5-carboxylate | 161798-03-4 | C18H21NO4S | 347.435 |
2-(3-醛基-4-羟基苯基)-4-甲基噻唑-5-羧酸乙酯 | ethyl 2-(3-formyl-4-hydroxyphenyl)-4-methylthiazole-5-carboxylate | 161798-01-2 | C14H13NO4S | 291.328 |
2-(4-羟基苯基)-4-甲基噻唑-5-羧酸乙酯 | ethyl 2-(4-hydroxyphenyl)-4-methylthiazole-5-carboxylate | 161797-99-5 | C13H13NO3S | 263.317 |
A series of febuxostat based new chemical entities was synthesized using microwave method and characterized by NMR, mass and FT-IR spectral studies. Molecular docking of febuxostat amide nucleus substitution compounds 8c (-7.91kcal/mol), 8g (-7.94 kcal/mol) exhibiting high binding energy against ALK receptors. Theoretical investigation of MEPs, HOMO, LUMO and energy gap of HOMO-LUMO were calculated by B3LYP/6-31G method. Among the tested compounds, methoxy substituted compound 8g showed highest antibacterial activity against S. aereus and B. subtilis.